Zosano Pharma Corporation (ZSAN)

US98979H3012 - Common Stock

0.5576  +0.04 (+7.23%)

After market: 0.5459 -0.01 (-2.1%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-3-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
660.00K790.00K220.00K0.000.00
Cost Of Goods
N/A800.00K170.00KN/AN/A
Gross Profit
N/A-10.00K50.00KN/AN/A
Operating Expenses
30.89M31.52M32.81M37.20M34.87M
Research and Development
20.13M20.97M21.62M25.39M25.51M
Selling, General, and Administrative Expenses
10.76M10.55M11.19M11.81M9.36M
Operating Income
-30.87M-31.53M-32.76M-37.20M-34.87M
Interest Income/Expense
-160.00K-190.00K-700.00K-320.00K0.00
Other Income/Expense
160.00K180.00K90.00K-80.00K20.00K
Non Recurring Items
-24.33M1.61MN/A0.00-510.00K
Income Before Taxes
-55.19M-29.93M-33.37M-37.59M-35.36M
Income Tax
N/A0.000.000.000.00
Net Income
-55.19M-29.93M-33.37M-37.59M-35.36M
EBITDA
-29.31M-29.78M-31.33M-36.52M-34.11M
 
Per Share Data
EPS Diluted Total Ops
-14.50-9.35-0.49-2.29-3.74
Non GAAP EPS
-8.41-6.73-0.57-2.34N/A
 
Statistics
Gross Profit Margin
N/A-1.27%22.73%N/AN/A
Profit Margin
-8362.12%-3788.61%-15168.18%N/AN/A
Operating Profit Margin
-4677.27%-3991.14%-14890.91%N/AN/A

All data in USD

Charts